The precision medicine market size has grown rapidly in recent years. It will grow from $80.15 billion in 2024 to $88.73 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to increase in cancer prevalence, increasing prevalence of mental health disorders, increased prevalence of respiratory diseases, increasing funding, increased geriatric population, increase in pharmaceutical R&D expenditure and increased healthcare expenditure.
The precision medicine market size is expected to see strong growth in the next few years. It will grow to $129.37 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to the increasing geriatric population, increasing prevalence of cancer, high potential of emerging economies, emergence of novel pathogenic infestations, increasing research and development spending and rise in healthcare expenditure. Major trends in the forecast period include adopting artificial intelligence technologies for improving competitiveness, offering diagnosis and personalized treatment for immune-mediated diseases, investing in increased research and development activities and forming collaborations and partnerships with technology and healthcare entities to improve their product portfolios.
Get Your Free Sample of The Global Precision Medicine Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5301&type=smp
Which Market drivers have played a significant role in driving the precision medicine market?
The rising prevalence of cancer is projected to fuel the growth of the precision medicine market. Cancer is one of the main causes of death worldwide, with one out of every five individuals developing cancer at some point in their lives. Precision medicine in cancer entails analyzing DNA from tumors to find mutations or other genetic abnormalities that cause cancer. Physicians may therefore be able to choose a treatment for a specific patient’s cancer that best fits, or targets, the tumor DNA alterations. For instance, in February 2024, according to the World Health Organization, a Switzerland-based specialized agency responsible for international public health, by 2050, over 35 million new cancer cases are projected, representing a 77% increase from the estimated 20 million cases in 2022. Therefore, the rising prevalence of cancer drives the growth of the precision medicine market.
What are the key segments within the precision medicine market?
The precision medicine market covered in this report is segmented –
1) By Technology: Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Other Technology
2) By Application: Oncology, Respiratory Diseases, Central Nervous System Disorders, Immunology, Genetic Diseases, Other Applications.
3) By End-Use: Pharmaceutical Companies, Diagnostic Companies, Healthcare And IT Firms, Others
Subsegments:
1) By Big Data Analytics: Predictive Analytics, Prescriptive Analytics, Data Mining
2) By Bioinformatics: Genomic Data Analysis, Proteomics Data Analysis, Metabolomics Data Analysis
3) By Gene Sequencing: Next-Generation Sequencing (NGS), Sanger Sequencing, Whole Genome Sequencing
4) By Drug Discovery: Target Identification And Validation, Lead Compound Discovery, Preclinical And Clinical Trials
5) By Companion Diagnostics: Biomarker Testing, Genomic Profiling, Companion Diagnostic Tests
6) By Other Technology: Personalized Treatment Plans, Telemedicine And Digital Health Solutions, Wearable Health Technology
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/precision-medicine-global-market-report
Which key players are shaping the precision medicine market?
Major companies operating in the precision medicine market include Quest Diagnostics, Thermo Fisher Scientific Inc., Roche Holding AG, Medtronic plc, Novartis AG, Pfizer Inc., Qiagen, AstraZeneca plc., Abbott Laboratories, Nordic Bioscience A/S, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo, China National Pharmaceutical Group Co., Ltd., GE Healthcare, Randox Laboratories, Almac Group, Sun Pharma, Nichi-Iko Pharmaceutical Co., Ltd., Daewoong Pharmaceutical Co.,Ltd, GlaxoSmithKline, Teva UK Limited, Vectura Group, Merck & Co., Boehringer Ingelheim, Mylan, Zentiva, Sanofi, Apotex, Gilead Sciences, Bayer, AbbVie Inc., Amgen, Janssen Pharmaceutica, Accord Healthcare Inc., Acerus Precision Medicine Corporation, AA Pharma Inc, Sanfer, LABORATORIOS SENOSIAIN SA DE CV, Siegfried Rhein, Biocrates LifeSciences, Nanostring Technologies, Tepnel Pharma Services, Intomics, Silicon Biosystems, EMS Pharma, Eurofarma, Biolab Farmaceutica, Cristalia, União Quimica
Which transformative trends will shape the precision medicine market landscape?
The rising number of partnerships and acquisitions among precision medicine companies is enabling them to expand their approaches to both oncology and non-oncology areas. Precision medicine is undergoing continuous research and development in new areas, collaboration and partnership helps the firms to enhance their capabilities and approaches. For instance, in September 2022, GSK plc, a UK-based pharmaceutical company, expanded its collaboration with Tempus, a US-based precision medicine company. This three-year partnership aims to improve clinical trial design, speed up patient enrollment, and identify drug targets by utilizing Tempus’ AI-enabled platform and extensive de-identified patient data. The collaboration builds on their previous work and is expected to enhance GSK’s R&D capabilities, particularly in oncology.
How do regional factors impact the precision medicine market, and which region is the largest contributor?
The countries covered in the precision medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
What Does The Precision Medicine Market Report 2025 Offer?
The precision medicine market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Precision medicine refers to a type of medication that prevents, detects, or treats disease using knowledge about a person’s genes or proteins. To choose a treatment that may be most effective for a person, precision medicine considers their genetics, environment, and lifestyle.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5301
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
